• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Edesa Biotech Inc (NQ: EDSA )

    4.480 +0.030 (+0.67%)
    Streaming Delayed Price Updated: 3:48 PM EDT, Aug 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,866
    Open 4.460
    Bid (Size) 4.090 (2)
    Ask (Size) 4.990 (5)
    Prev. Close 4.450
    Today's Range 4.460 - 4.790
    52wk Range 2.460 - 8.333
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    EDSA Stock Earnings: Edesa Biotech Beats EPS for Q3 2024
    EDSA stock results show that Edesa Biotech beat analyst estimates for earnings per share the third quarter of 2024. 
    Via InvestorPlace
    BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS
    Via ACCESSWIRE

    Performance

    YTD
    -4.27%
    -4.27%
    1 Month
    -13.85%
    -13.85%
    3 Month
    +5.26%
    +5.26%
    6 Month
    -10.60%
    -10.60%
    1 Year
    -26.61%
    -26.61%

    More News

    Read More
    EDSA Stock Earnings: Edesa Biotech Beats EPS for Q2 2024
    Via InvestorPlace
    Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
    Via ACCESSWIRE
    Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
    Via ACCESSWIRE
    Edesa Biotech to Participate in Upcoming Investor Conferences
    Via ACCESSWIRE
    Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference
    Via ACCESSWIRE
    Edesa Biotech to Participate in Barclays Global Healthcare Conference
    Via ACCESSWIRE
    Edesa Biotech to Participate in Upcoming Dermatology Meetings
    Via ACCESSWIRE
    Edesa Biotech Reports Fiscal 1st Quarter 2024 Results
    Via ACCESSWIRE
    Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week
    Via ACCESSWIRE
    EDSA Stock Earnings: Edesa Biotech Beats EPS for Q4 2023
    Via InvestorPlace
    Edesa Biotech Reports Fiscal Year 2023 Results
    Via ACCESSWIRE
    Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Exposures Product Safety
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study
    Via ACCESSWIRE
    Edesa Biotech to Present at Dermatology Drug Development Summit
    Via ACCESSWIRE
    Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech’s ARDS Drug
    Via ACCESSWIRE
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
    Via Benzinga
    Why Comtech Telecommunications Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why Is Infectious Disease Player Edesa Biotech Stock Soaring Today?
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.